Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Frontiers in Immunology|May 23, 2024
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacityWilhelm A J W Vos, Adriana Navas, Elise M G Meeder, et al.
AIDS (London, England)|April 21, 2026
HIV immunological non-responders show low SKAP1 concentration and DNA hypermethylation in the SKAP1 promotor region: Low Skap1 in HIV Immunological Non-RespondersWilhelm Ajw Vos, Suzanne De Ruijten, Xun Jiang, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Lancet (London, England)|May 7, 2019
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Journal of Infectious Diseases|November 19, 2022
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary VaccinationMarlou J Jongkees, Daryl Geers, Kathryn S Hensley, et al.
Plos Medicine|January 7, 2023
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Plos Medicine|October 27, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Frontiers in Immunology|January 6, 2023
The 2000HIV study: Design, multi-omics methods and participant characteristicsWilhelm A J W Vos, Albert L Groenendijk, Marc J T Blaauw, et al.
Open Forum Infectious Diseases|December 4, 2015
Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control StudyJoost W Vanhommerig, Femke A E Lambers, Janke Schinkel, et al.
Pageof 10